Kenya confirms four additional Ebola cases, raising total to seven

The Kenyan government announced on Saturday that four more individuals have tested positive for the Bundibugyo strain of Ebola, bringing the nation’s confirmed case count to seven. Health officials said three of the new patients are health workers who cared for the country’s first Ebola victim, while the fourth is a family member of that same patient.

The relative had been placed under quarantine on October 6, according to a statement posted by the Ministry of Health on X. The announcement follows the confirmation of three cases the previous day, which included a primary contact and close relative of the first two patients.

Kenya’s cases are linked to the ongoing Ebola outbreak in the Democratic Republic of the Congo, where more than 9,000 infections and over 4,300 deaths have been recorded since the disease was first identified in May. The index case in Kenya died on October 5 after spending a month ill in the DRC and traveling to Nairobi on October 3. These are the first known instances of the virus being transmitted within Kenya.

Of the 130 contacts identified for the first patient, 128 have been placed under quarantine, representing a 98.5 percent compliance rate that exceeds the global benchmark of 85 percent needed to interrupt transmission. The ministry says it has traced and isolated nearly all contacts and sees no evidence of community spread.

Kenyan authorities have quickly stepped up airport screening and launched a hotline for anyone who believes they may have been exposed. Some experts, however, have raised questions about how the index patient was able to evade health checks upon returning and come into contact with so many people.

Ebola spreads through direct contact with the bodily fluids of an infected person or through contaminated objects such as bedding and clothing. The current outbreak involves the Bundibugyo strain, for which no approved vaccine or treatment exists, complicating containment efforts. Research into vaccines targeting this strain is ongoing, with several candidates now in early human trials.